Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

Clicks: 287
ID: 105232
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
fukuhara2020retreatmentleukemia Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fukuhara, Noriko;Yamamoto, Go;Tsujimura, Hideki;Chou, Takaaki;Shibayama, Hirohiko;Yanai, Tomoko;Shibuya, Kazunori;Izutsu, Koji;
Journal Leukemia & lymphoma
Year 2020
DOI
10.1080/10428194.2019.1654100
URL
Keywords
allogeneic stem cell transplantation malignant lymphoma cd204 tumor-associated macrophage

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.